| |
| |
|
| Insider
Information: |
Turner Daniel K III |
| Relationship: |
10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
695,505 |
|
|
Indirect Shares
|
2,337,381 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,401,415 |
|
|
| Total
Shares |
3,032,886 |
|
|
| Total
Value |
$1,401,415 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
2010-03-18 |
695,505 |
2005-12-20 |
671,855 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
Director |
2007-05-01 |
0 |
2011-12-22 |
377,958 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2007-05-07 |
0 |
2007-05-07 |
488,100 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2009-01-30 |
0 |
2011-03-29 |
627,539 |
Premium* |
|
|
Mindbody Inc. |
MB |
10% Owner |
|
0 |
2015-06-24 |
0 |
Premium* |
|
|
Si-Bone, Inc. |
SIBN |
10% Owner |
2018-10-19 |
0 |
2018-10-19 |
171,929 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SIBN |
Si-Bone, Inc. |
10% Owner |
– – • |
2018-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
2,029,715 |
171,929 |
0 |
- |
|
| MB |
Mindbody Inc. |
10% Owner |
– – • |
2015-06-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(930,982) |
0 |
0 |
- |
|
| MB |
Mindbody Inc. |
10% Owner |
– – • |
2015-06-24 |
4 |
A |
$0.00 |
$0 |
I/I |
610,222 |
594,349 |
0 |
- |
|
| MB |
Mindbody Inc. |
10% Owner |
– – • |
2015-06-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
320,760 |
|
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2011-12-22 |
4 |
B |
$1.45 |
$82,946 |
I/I |
57,204 |
377,958 |
2.1 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • – |
2011-03-29 |
4 |
S |
$8.17 |
$1,061,879 |
I/I |
(130,000) |
569,361 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2010-12-23 |
4 |
S |
$0.00 |
$0 |
I/I |
(48,057) |
498,712 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2010-12-22 |
4 |
S |
$8.25 |
$428,530 |
I/I |
(51,943) |
546,769 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2010-12-13 |
4 |
S |
$0.00 |
$0 |
I/I |
(266,365) |
598,712 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2010-12-10 |
4 |
S |
$0.00 |
$0 |
I/I |
(333,635) |
865,077 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
– – • |
2010-03-18 |
4 |
S |
$6.38 |
$9,573,600 |
D/D |
(1,500,000) |
695,505 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2009-12-17 |
4 |
S |
$7.55 |
$755,000 |
I/I |
(100,000) |
1,198,712 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2009-09-22 |
4 |
S |
$10.22 |
$1,021,820 |
I/I |
(100,000) |
1,298,712 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2009-09-17 |
4 |
S |
$9.28 |
$928,000 |
I/I |
(100,000) |
1,398,712 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2009-09-16 |
4 |
S |
$8.93 |
$365,068 |
I/I |
(40,904) |
1,498,712 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2009-09-15 |
4 |
S |
$8.96 |
$1,216,315 |
I/I |
(135,701) |
1,539,616 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2009-09-14 |
4 |
S |
$9.00 |
$210,590 |
I/I |
(23,395) |
1,675,317 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • • |
2009-09-11 |
4 |
S |
$12.56 |
$131,635 |
I/I |
(10,450) |
58,178 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • • |
2009-09-10 |
4 |
S |
$13.00 |
$397,633 |
I/I |
(30,574) |
59,628 |
0 |
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • • |
2009-09-09 |
4 |
S |
$13.11 |
$460,147 |
I/I |
(35,030) |
62,202 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
– – • |
2009-07-08 |
4 |
A |
$1.05 |
$893,615 |
D/D |
851,062 |
2,195,505 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
|
– – – |
2009-07-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,344,443 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
Director |
– • – |
2009-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,305,342 |
67,232 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
Director |
– • – |
2008-12-05 |
4 |
B |
$3.46 |
$1,038,450 |
I/I |
300,000 |
1,698,712 |
2.1 |
- |
|
| NGSX |
Neurogesx Inc |
Director |
– • – |
2007-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
953,199 |
488,100 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
